ArticleFrontiers in veterinary science2026
Prognostic utility of red blood cell distribution width-based ratios and their individual components for mortality prediction in dogs with acute pancreatitis.
Article in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prognostic assessment is critical in dogs with acute pancreatitis (AP). Composite biomarkers such as the red blood cell distribution width (RDW)-to-albumin ratio (RAR) and hemoglobin-to-RDW ratio (HRR) have shown prognostic value in human critical care but have not been evaluated in canine AP. Methods: A retrospective cohort study was conducted in 80 dogs with AP and 10 healthy controls. The diagnostic and prognostic utility of admission HRR and RAR was compared with that of their individual components measured at admission (RDW, hemoglobin and albumin). Outcome was classified as survival or non-survival to hospital discharge. Receiver operating characteristic (ROC) curve analysis and multivariable logistic regression were performed. Results: The overall mortality rate was 33.75%. Non-survivors presented with significantly lower hemoglobin, albumin and HRR values and significantly higher RDW values than survivors, whereas RAR did not differ between outcome groups. Among the variables evaluated, hemoglobin showed the highest discriminatory performance (AUC = 0.704; 95% CI: 0.583-0.812), followed by HRR (AUC = 0.669; 95% CI: 0.547-0.790), RDW (AUC = 0.663; 95% CI: 0.540-0.786), CAPCSI (AUC = 0.658) and albumin (AUC = 0.634; 95% CI: 0.506-0.757). In the multivariable model including age, hemoglobin, albumin, RDW and CAPCSI, only CAPCSI remained independently associated with survival (adjusted OR = 0.612; 95% CI: 0.403-0.929; Discussion: Integrating erythrocyte indices into composite ratios offered no clinical advantage over evaluating individual markers in dogs with acute pancreatitis. Among the laboratory variables assessed, hemoglobin showed the highest discriminatory performance, although its overall prognostic accuracy remained moderate. These findings suggest that erythrocyte-derived variables may serve as adjunctive prognostic markers in dogs with AP but should be interpreted alongside established clinical assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.